questions about the safety of Multaq (dronedarone) for atrial fibrillation

February 2011

Please see the July 2011 FDA warning concerning Multaq and an increased risk of serious adverse events

New concerns are raising questions about the safety of Multaq (dronedarone) for atrial fibrillation.

This is especially important since the most recent guidelines recommend Multaq before amiodarone for A fib in many cases.

Multaq is less effective than amiodarone...but it SEEMED safer.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote